153 related articles for article (PubMed ID: 29456733)
41. Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.
Xie W; Liu X; Chen Q; Ma M; Yang X; Gong B; Sun T; Chen J
Oncol Lett; 2019 Mar; 17(3):3173-3180. PubMed ID: 30867747
[TBL] [Abstract][Full Text] [Related]
42. Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.
Xing L; Xu L; Zhang Y; Che Y; Wang M; Shao Y; Qiu D; Yu H; Zhao F; Zhang J
Front Oncol; 2022; 12():925041. PubMed ID: 35814468
[TBL] [Abstract][Full Text] [Related]
43. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
44. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
[No Abstract] [Full Text] [Related]
45. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
[TBL] [Abstract][Full Text] [Related]
46. MECP2 promotes the migration and invasion of gastric cancer cells by modulating the Notch1/c-Myc/mTOR signaling pathways by suppressing FBXW7 transcription.
Zhao L; Wang X; Yang J; Jiang Q; Zhang J; Wu F; Ni L; Tong D; Huang C
Am J Cancer Res; 2022; 12(11):5183-5204. PubMed ID: 36504898
[TBL] [Abstract][Full Text] [Related]
47. E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.
Chong Z; Bao C; He J; Chen T; Zhong L; Li G; Li H; Fang L; Song Y; Fu G; Yang X; Lai L; Liu Y; Wang Q
Cell Mol Immunol; 2018 Dec; 15(12):1057-1070. PubMed ID: 30275535
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
49. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of miR-106a suppresses migration and invasion and enhances radiosensitivity of hepatocellular carcinoma cells by upregulating FBXW7.
Deng P; Wu Y
Int J Clin Exp Pathol; 2019; 12(4):1184-1193. PubMed ID: 31933933
[TBL] [Abstract][Full Text] [Related]
51. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
52. MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition.
Zhou L; Shi L; Guo H; Yao X
Tumour Biol; 2015 Sep; ():. PubMed ID: 26409454
[TBL] [Abstract][Full Text] [Related]
53. High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.
Xiong J; Liu Y; Jiang L; Zeng Y; Tang W
Jpn J Clin Oncol; 2016 Apr; 46(4):378-84. PubMed ID: 26848077
[TBL] [Abstract][Full Text] [Related]
54. Low expression of the ubiquitin ligase FBXW7 correlates with poor prognosis of patients with colorectal cancer.
Liu H; Wang K; Fu H; Song J
Int J Clin Exp Pathol; 2018; 11(1):413-419. PubMed ID: 31938126
[TBL] [Abstract][Full Text] [Related]
55. Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair.
Lan H; Sun Y
Front Cell Dev Biol; 2021; 9():751574. PubMed ID: 34760892
[TBL] [Abstract][Full Text] [Related]
56. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
57. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
[TBL] [Abstract][Full Text] [Related]
58. PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1.
Wang H; Jiang Z; Na M; Ge H; Tang C; Shen H; Lin Z
Oncol Lett; 2017 Sep; 14(3):2933-2939. PubMed ID: 28928831
[TBL] [Abstract][Full Text] [Related]
59. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
[TBL] [Abstract][Full Text] [Related]
60. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
